Radioimmunotherapy - Hot new treatment for lymphoma

New England Journal of Medicine

Volumn 352, Issue 5, 2005, Pages 496-498

  Connors, Joseph M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; IBRITUMOMAB TIUXETAN; PREDNISONE; RITUXIMAB; TOSITUMOMAB I 131; VINCRISTINE;

B LYMPHOCYTE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; DISEASE COURSE; EDITORIAL; FLU LIKE SYNDROME; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HYPOTHYROIDISM; LYMPHOCYTE DEPLETION; MYELODYSPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOTHERAPY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; HUMANS; LYMPHOMA, FOLLICULAR; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 12944276968     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe048291     Document Type: Editorial

References (8)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Vol. 3 of World Health Organization classification of tumours. Lyon, France: IARC Press, 2001.
2. Canadian Cancer Society. Non-Hodgkin's lymphoma. (Accessed January 14, 2005, at http://www.cancer.ca/ccs/internet/standard/ 0,3182, 3172_367655_194217223_langId-en,00.html.)
3. Webb A, Cunningham D, Cotter F, et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997;349:1137-41.
4. Cheson BD. Radioimmunotherapy of non-Hodgkin lymphomas. Blood 2003;101:391-8.
5. Witzig TE, Gordon LI, Cabanillas F, et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 2002;20:2453-63.
6. Davies AJ, Rohatiner AZ, Howell S, et al. Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 2004;22:1469-79.
7. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 2005;352:441-9.
8. Kaminski MS, Tuck M, Estes J, et al. Iodine 131 tositumomab therapy for previously untreated follicular lymphoma (FL). Prog Proc Am Soc Clin Oncol 2000;19:5a. abstract.